Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2011-06-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm200400mPMID 21682298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series.

  2011cited by this paper
• Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.

  2010cited by this paper
• Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulators.

  2010cited by this paper
• Hydroxy cycloalkyl fused pyridone carboxylic acid M(1) positive allosteric modulators.

  2010cited by this paper
• Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.

  2009cited by this paper
• A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning

  2009cited by this paper
• Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

  2009cited by this paper
• Preparation of 4-heteroaryl-4-cyanopiperidines via SNAr substitution reactions

  2009cited by this paper
• Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation

  2009cited by this paper
• Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

  2008cited by this paper
• Muscarinic acetylcholine receptors as CNS drug targets.

  2008cited by this paper
• RELATIONSHIP BETWEEN EXPOSURE AND NONSPECIFIC BINDING OF THIRTY-THREE CENTRAL NERVOUS SYSTEM DRUGS IN MICE

  2005cited by this paper
• Design and synthesis of highly sensitive and selective fluorescein-derived magnesium fluorescent probes and application to intracellular 3D Mg2+ imaging.

  2004cited by this paper
• Discovery of an ectopic activation site on the M(1) muscarinic receptor.

  2002cited by this paper
• In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results.

  2001cited by this paper
• Muscarinic agonists and antagonists in the treatment of Alzheimer's disease.

  2001cited by this paper
• Abnormalities of neural circuitry in Alzheimer's disease

  1998cited by this paper
• Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.

  1997cited by this paper
• Modality-specific retrograde amnesia of fear.

  1992cited by this paper
• The molecular basis of muscarinic receptor diversity.

  1989cited by this paper
• New subtypes of muscarinic acetylcholine receptors.

  1989cited by this paper

• Target-Agnostic P-Glycoprotein Assessment Yields Strategies to Evade Efflux, Leading to a BRAF Inhibitor with Intracranial Efficacy.

  2022cites this paper
• A Mild Silica Gel Promoted Synthesis and Initial Functional Study of Tetrapyridyl Tetrahydropyrrolopyrrolones.

  2022cites this paper
• Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits

  2022cites this paper
• Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 1.

  2022cites this paper
• Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias

  2021cites this paper
• Recent advances towards the synthesis of 4H-quinolizin-4-one

  2020cites this paper
• One-Pot Synthesis of 3-Substituted 4H-Quinolizin-4-ones via Alkyne Substrate Control Strategy.

  2020cites this paper
• Restoring Agonist Function at a Chemogenetically Modified M1 Muscarinic Acetylcholine Receptor.

  2020cites this paper
• Bicyclic 6-6 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: No Extra Heteroatom

  2020cites this paper
• Current Advances in Allosteric Modulation of Muscarinic Receptors

  2020cites this paper
• Allosteric modulators targeting GPCRs

  2020cites this paper
• Muscarinic receptor 1 allosteric modulators stimulate colorectal emptying in dog, mouse and rat and resolve constipation

  2019cites this paper
• Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.

  2018cites this paper
• MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development Candidate.

  2018cites this paper
• Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.

  2018cites this paper
• Probing the binding site of novel selective positive allosteric modulators at the M1 muscarinic acetylcholine receptor

  2018cites this paper
• Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622

  2018influential citation
• Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor.

  2017cites this paper
• Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors

  2017cites this paper
• High-Throughput Agonist Shift Assay Development for the Analysis of M1-Positive Allosteric Modulators

  2017cites this paper
• Allosteric modulators targeting CNS muscarinic receptors.

  2017cites this paper
• Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity.

  2017cites this paper
• Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors

  2016influential citation
• The Cholinergic System: An Emerging Drug Target for Schizophrenia.

  2016cites this paper
• Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects.

  2016cites this paper
• Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284

  2016cites this paper
• Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M1 Receptor Activation.

  2016influential citation
• Novel Therapeutic Strategies for Dementia.

  2016cites this paper
• Allosteric modulation of cholinergic system: Potential approach to treating cognitive deficits of schizophrenia

  2016cites this paper
• Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey

  2015cites this paper
• Destruction and Construction: Application of Dearomatization Strategy in Aromatic Carbon-Nitrogen Bond Functionalization.

  2015cites this paper
• Synthesis and pharmacological investigation of allosteric and bitopic ligands for the M₁ muscarinic acetylcholine receptor

  2015cites this paper
• Conception, synthèse et évaluation de nouveaux ligands antagonistes de récepteurs A2a

  2015cites this paper
• Diastereoselective synthesis of quinolizidin-4-one and indolizidin-3-one derivatives with a spirocyclic motif via cascade cyclization using a gold(I)/Brønsted acid relay catalysis

  2015cites this paper
• Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators.

  2015cites this paper
• The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.

  2015cites this paper
• The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys

  2015influential citation
• Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2.

  2015cites this paper
• Mechanistic Insights into Allosteric Structure-Function Relationships at the M1 Muscarinic Acetylcholine Receptor*

  2014cites this paper
• Muscarinic Acetylcholine Receptor Activators

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

  2014cites this paper
• Discovery of naphthyl-fused 5-membered lactams as a new class of m1 positive allosteric modulators.

  2014cites this paper
• Pharmacokinetics and tissue distribution of a M1 muscarinic acetylcholine receptor positive allosteric potentiator, benzyl quinolone carboxylic acid

  2014cites this paper
• Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators.

  2014cites this paper
• Silver-mediated C–H bond functionalization: one-pot to construct substituted indolizines from 2-alkylazaarenes with alkynes

  2014cites this paper
• Scope and limitations of the synthesis of functionalized quinolizidinones and related compounds by a simple precursor approach via addition of lithium allylmagnesates to 2-pyridones and RCM as key steps

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs interacting with Receptors. Update 2014

  2014cites this paper
• SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs).

  2014cites this paper
• Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism.

  2013cites this paper
• Cyanide anion as a leaving group in nucleophilic aromatic substitution: synthesis of quaternary centers at azine heterocycles.

  2013cites this paper
• Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.

  2013cites this paper
• Recent Developments in Inter- and Intramolecular Enolate Arylation

  2013cites this paper
• Identification of amides as carboxylic Acid surrogates for quinolizidinone-based m1 positive allosteric modulators.

  2012cites this paper
• M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease

  2012cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

  2012cites this paper
• Drug Design Strategies for GPCR Allosteric Modulators.

  2012cites this paper
• The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque

  2012cites this paper
• Novel M1 allosteric ligands: a patent review

  2012cites this paper
• Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode.

  2012cites this paper
• Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe ML071.

  2011cites this paper